Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection
- PMID: 19420160
- DOI: 10.1099/vir.0.010967-0
Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection
Abstract
Human cytomegalovirus (HCMV) encodes several highly polymorphic envelope glycoproteins; however, the biological relevance of this polymorphism is unclear. Glycoprotein N (gN) is one member of this polymorphic protein family. Four major gN genotypes (gN1-4) have been identified. We have tested the hypothesis that the gN polymorphism represents a mechanism to evade a neutralizing antiviral antibody response. Four recombinant viruses that differed only in the expression of the gN genotype were constructed on the genetic background of HCMV strain AD169. Exchange of gN genotypes had a minor detectable influence on virus replication, gN expression and gN-gM complex formation. Randomly selected human sera were analysed for neutralizing activity against the recombinant viruses. Of these, 70 % showed no difference in neutralizing titre between the viruses, whereas 30 % showed strain-specific neutralization. Differences in 50 % neutralization titre reached >8-fold. Viruses expressing the gN4 genotype were neutralized significantly better than those expressing the other gN genotypes. Strain specificity, or lack thereof, could not be attributed to the presence or absence of anti-gN antibodies, as all sera contained antibodies reacting with gN (as determined by ELISA). Thus, polymorphism of gN could contribute to evasion of an efficient neutralizing-antibody response and facilitate reinfection in previously seropositive individuals.
Similar articles
-
Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N.Clin Vaccine Immunol. 2012 Jun;19(6):909-13. doi: 10.1128/CVI.00092-12. Epub 2012 Apr 4. Clin Vaccine Immunol. 2012. PMID: 22492744 Free PMC article.
-
Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.PLoS Pathog. 2012;8(10):e1002999. doi: 10.1371/journal.ppat.1002999. Epub 2012 Oct 25. PLoS Pathog. 2012. PMID: 23133379 Free PMC article.
-
DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.Vaccine. 2007 Apr 30;25(17):3319-27. doi: 10.1016/j.vaccine.2007.01.011. Epub 2007 Jan 16. Vaccine. 2007. PMID: 17287056
-
Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein n (gN) paradigm.Hum Immunol. 2004 May;65(5):387-94. doi: 10.1016/j.humimm.2004.02.023. Hum Immunol. 2004. PMID: 15172436 Review.
-
Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.Viruses. 2021 Jun 9;13(6):1106. doi: 10.3390/v13061106. Viruses. 2021. PMID: 34207868 Free PMC article. Review.
Cited by
-
A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targeting.MAbs. 2012 Jan-Feb;4(1):45-56. doi: 10.4161/mabs.4.1.18498. MAbs. 2012. PMID: 22327429 Free PMC article.
-
Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.Microbiol Mol Biol Rev. 2016 Jun 15;80(3):663-77. doi: 10.1128/MMBR.00018-16. Print 2016 Sep. Microbiol Mol Biol Rev. 2016. PMID: 27307580 Free PMC article. Review.
-
Cytomegalovirus Genetic Diversity and Evolution: Insights into Genotypes and Their Role in Viral Pathogenesis.Pathogens. 2025 Jan 9;14(1):50. doi: 10.3390/pathogens14010050. Pathogens. 2025. PMID: 39861011 Free PMC article. Review.
-
Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity.J Infect Dis. 2020 Mar 5;221(Suppl 1):S1-S8. doi: 10.1093/infdis/jiz464. J Infect Dis. 2020. PMID: 32134479 Free PMC article. Review.
-
Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N.Clin Vaccine Immunol. 2012 Jun;19(6):909-13. doi: 10.1128/CVI.00092-12. Epub 2012 Apr 4. Clin Vaccine Immunol. 2012. PMID: 22492744 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical